Background-Few studies in Hispanic women have examined the relation between adult body size and risk of premenopausal breast cancer defined by hormone receptor status.
Introduction
Body mass index (BMI), a measure of overall adiposity, has been associated with decreased risk of premenopausal breast cancer (BC) (1-3), whereas waist circumference and waist-tohip ratio (WHR), two commonly used measures of abdominal or central adiposity, have been associated with increased risk (3) (4) (5) . These findings are based on studies conducted in primarily non-Hispanic white (NHW) women. Only a few studies have reported on body size associations in premenopausal U.S. Hispanic women (6) (7) (8) (9) (10) , and the findings are not consistent. Therefore, it is unclear whether the effects of overall and abdominal obesity on premenopausal BC risk in Hispanics are different from those in NHWs (11) . Given the higher prevalence of overweight and obesity in Hispanics than NHWs (12) , further investigation of the relation between body size and breast cancer risk in Hispanics is warranted.
In this report, we analyzed data for Hispanic and NHW women from two large populationbased case-control studies that were harmonized and pooled for the Breast Cancer Health Disparities Study (13) . We assessed associations of overall and abdominal adiposity with risk of premenopausal BC defined by estrogen receptor (ER) and progesterone receptor (PR) status, which are important in characterizing risk profiles for hormone-related exposures such as body size (14) . We also examined whether genetic ancestry among Hispanic women modified the body size associations, given our previous finding that overall and abdominal obesity are more common in Hispanic women with higher Indigenous American (IA) ancestry (15) .
2002. Controls were identified through random-digit dialing and were frequency matched to cases on race/ethnicity and the expected 5-year age distribution of cases. Self-reported race/ ethnicity and eligibility for several studies were assessed by a telephone screening interview, with participation rates of 89% among 15,573 cases contacted (alive, valid address, no physician refusal) and 92% among 3,547 controls contacted. For the SFBCS, women eligible for an in-person interview included all Hispanic cases diagnosed from 1995-2002, all African American cases diagnosed from 1995-1999, and a sample of NHW cases diagnosed from 1995-1999. Given the large number of diagnoses in NHW women, they were randomly sampled at 10%. Interview data were obtained for 1,715 cases, including 1,119 (89%) Hispanics and 596 (86%) NHWs, and 2,108 controls, including 1,462 (88%) Hispanics and 646 (83%) NHWs. Median time between diagnosis and interview was 15.4 months. The pooled analysis included Hispanics and NHWs only; body size associations for African Americans were reported elsewhere (9) .
4-Corners Breast Cancer Study (4-CBCS)
The 4-CBCS included NHW, Hispanic, and Native American (NA) women from nonreservation areas in Arizona, Colorado, New Mexico, and Utah (8) . The state-wide cancer registries identified 5,256 cases aged 25-79 years with in situ or invasive BC diagnosed between October 1999 and May 2004; controls were selected from the populations living in the four states and were frequency matched to cases on race/ethnicity and expected 5-year age distribution. A total of 3,761 cases were contacted and 2,556 completed the in-person interview, including 873 Hispanics/NAs (63%) and 1,683 NHWs (71%). Of 6,152 controls contacted, 2,605 completed the interview, including 936 (36%) Hispanics/NAs and 1,669 (47%) NHWs. The number of NAs (55 cases, 73 controls) was too small for separate analysis and they were combined with Hispanics. Cases were restricted to those with a first primary invasive breast cancer (662 Hispanics/NAs, 1,246 NHWs). Median time between diagnosis and interview was 17.8 months.
Data Collection
The two studies used similar structured questionnaires in English or Spanish to collect information on body size and other BC risk factors up to the reference year (defined as the calendar year prior to diagnosis for cases or selection into the study for controls). Trained professional bilingual interviewers administered the questionnaires in English or Spanish and also measured standing height (with shoes removed) and weight (with light clothing) at the time of interview, using a portable stadiometer and scale, respectively. Waist and hip circumferences were measured using a linen tape (in SFBCS) or a flexible tape (in 4-CBCS). In SFBCS, height was measured to the nearest millimeter, weight to the nearest 0.20 kilogram, and waist and hip circumferences to the nearest millimeter. For each, three measurements were taken (except for two measurements of weight) and averaged (9) . In 4-CBCS, height was measured to the nearest 0.25 inch (in), weight to the nearest 0.50 pound (lb), and waist and hip circumferences to the nearest 0.50 in. For each, two measurements were taken (if they differed by >0.5 in for height, >1.0 in for waist or hip circumferences, or >1.0 lb for weight, a third measurement was taken) and averaged (8) . Information on estrogen receptor (ER) and progesterone receptor (PR) status was obtained from the respective cancer registries and was available for most premenopausal cases (84% in SFBCS, 79% in 4-CBCS).
Study Variables
Data from the two studies were harmonized according to common definitions (13) . Women were classified as premenopausal if they reported having menstrual periods during the reference year. Based on current language usage, a three-level acculturation index was created for Hispanics (low: Spanish speaking only; moderate: speaking more Spanish than English or Spanish and English equally; high: speaking more English than Spanish or English only). Current BMI was calculated as weight (in kg) divided by height (in meter) squared, based on measured height at interview and self-reported weight in the reference year. Self-reported weight before diagnosis was used since weight measured at interview may have been affected by disease-or treatment-related weight gain or loss. For study participants who declined the height measurement, self-reported height was used (3% of cases, 2% of controls); for individuals without self-reported weight, measured weight was used (1% of cases, 2% of controls). The two studies used slightly different approaches to assess young-adult weight. In SFBCS, young-adult BMI was based on self-reported weight at age 25-30 years for cases diagnosed from 1995-1998 and their matched controls, or on self-reported weight at age 20-29 years for cases diagnosed from 1998-2002 and their matched controls. In 4-CBCS, young-adult BMI was based on the average of weights reported at ages 15 years and 30 years. Weight gain was calculated as the difference between self-reported young-adult weight and self-reported weight in the reference year (or measured weight at interview if self-reported weight was not available). We calculated WHR as a measure of body fat distribution that reflects both adipose tissue (waist circumference) and muscle mass (hip circumference), and waist-to-height ratio (WHtR) as a measure of visceral adiposity independent of height (18) . Current BMI was classified as underweight to normal weight (<25.0 kg/m 2 ), overweight (25.0-29.9 kg/m 2 ), or obese (≥30.0 kg/m 2 ). All other body size variables were categorized according to the tertile or quartile distribution among premenopausal controls. We used the same cut-points for the two ethnic groups in order to facilitate the comparison of results. Additionally, we performed comparative analyses using ethnic-specific quantiles.
For a subset of study participants with stored DNA (in SFBCS, biospecimen collection began with cases diagnosed in April 1997 or later and their matched controls), we estimated genetic ancestry using 104 ancestry informative markers (AIMs) (13) . Hispanic women were classified according to being above or below the median (46%) of Indigenous American (IA) ancestry among premenopausal controls.
Statistical Analyses
Unconditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for the associations with body size variables. Polytomous logistic regression was used to compare ER+PR+ and ER−PR− case groups to a common control group. Other case groups in premenopausal women (97 ER+PR−, 41 ER−PR+) were too small for separate analyses. We also stratified the analyses by study (SFBCS, 4-CBCS) to evaluate consistency of results.
Multivariate analyses were adjusted for age (continuous) and study, and additionally, for factors significantly associated with risk of ER+PR+ or ER−PR− BC in our dataset. For ER +PR+ BC, analyses were adjusted for education, BC family history, age at menarche, number of full-term pregnancies, age at first full-term pregnancy, lifetime duration of breastfeeding, oral contraceptive use, and alcohol consumption; for ER−PR− BC, analyses were adjusted for alcohol consumption. Analyses in Hispanics additionally adjusted for language acculturation. Analyses of overall adiposity measures (current BMI, young-adult BMI, and weight gain) were adjusted for waist circumference (adjustment for WHtR produced the same results, data not shown), and analyses of abdominal adiposity were adjusted for current BMI. Additional adjustment for genetic ancestry did not alter the results (data not shown). Variables were categorized as noted in the footnotes of the tables. Linear trends were assessed across ordinal values of categorical variables. Significant differences in ORs between case groups were tested using the Wald statistic P-value, calculated from the polytomous regression model. Two-sided P-values are reported for tests of trend and tests of heterogeneity, with P-values <0.05 considered statistically significant.
Analyses in premenopausal women included 1,262 Hispanics (497 cases, 765 controls) and 1,101 NHWs (448 cases, 653 controls), after excluding individuals with missing data on covariates (89 cases, 92 controls) or ER/PR status (241 cases). The analyses by genetic ancestry were based on 861 Hispanics (327 cases, 534 controls). Statistical analyses used SAS version 9.3 software (SAS Institute, Inc., Cary, NC).
Results
Compared to controls, cases had higher education, younger age at menarche, fewer full-term pregnancies, later age at first full-term pregnancy, shorter duration of breast-feeding, and were more likely to have a first-degree family history of breast cancer (Table 1) . Among Hispanics, cases had higher English language acculturation than controls. Compared to NHW controls, higher proportions of Hispanic controls were overweight or obese (72% vs. 45%), had a waist size above the median of 87 cm (59% vs. 38%), and a young-adult BMI above the median of 21.7 kg/m 2 (63% vs. 35%) ( Table 2 ). Furthermore, Hispanics with higher IA ancestry (above the median of 46%) had higher body size measures than those with lower IA ancestry.
Body size and ER+PR+ breast cancer
For ER+PR+ BC (Table 3) , a suggestive positive trend with height was seen among Hispanics overall (P trend =0.05), with a stronger association among SFBCS Hispanics (high vs. low quartile: OR=1.85, 95% CI=0.94-3.61, P trend =0.02; data not shown). Higher youngadult and current BMI were associated with reduced risk, and adjustment for waist circumference strengthened the inverse associations. ORs for high (high vs. low quartile) young-adult BMI were similar for Hispanics (OR=0.41, P trend <0.01) and NHWs (OR=0.53, P trend =0.01), and findings were similar in SFBCS and 4-CBCS (data not shown). For current obesity (≥30 vs. <25 kg/m 2 ), inverse associations were statistically significant for Hispanics (OR=0.48, P trend <0.01) and NHWs in SFBCS (data not shown). For weight gain there was a suggestive inverse association among Hispanics, but the reduction in risk was statistically significant in SFBCS Hispanics only (high vs. low quartile: OR=0.36, 95% CI=0.18-0.72, P trend <0.01; data not shown).
Analyses of long-term elevated BMI showed that compared to women with both a lower young-adult BMI (<21.8 kg/m 2 ) and current normal-weight BMI (<25 kg/m 2 ), the greatest risk reductions of ER+PR+ BC were seen in Hispanics with higher young-adult BMI (≥21.8 kg/m 2 ) and current overweight (OR=0.39, 95% CI=0.24-0.63) or obesity (OR=0.35, 95% CI=0.19-0.62). Similarly, among NHWs, risk was significantly reduced among those with a higher young-adult BMI (≥21.8 kg/m 2 ) and current overweight (OR=0.49, 95% CI=0.26-0.91).
Among Hispanics, two-fold increased risk of ER+PR+ BC were associated with large waist and hip circumferences, and adjustment for current BMI strengthened the associations. For WHtR, the trend was of borderline significance (P trend =0.06). There were no significant associations with WHR. Among NHWs, abdominal obesity was not associated with ER+PR + BC, neither overall ( Table 3 ) nor in either study (data not shown);
Body size and ER−PR− breast cancer
For ER−PR− BC (Table 4 ), significant associations with body size were limited to Hispanic women. Height was associated with a two-fold increased risk, whereas young-adult BMI was associated with reduced risk, with a stronger inverse association after adjustment for abdominal obesity (≥30 vs. <25 kg/m 2 : OR=0.36, P trend <0.01). A significant inverse association also was seen for current BMI, when adjusted for abdominal obesity, although no significant association remained after additional adjustment for young-adult BMI.
Large waist and hip circumferences and high WHtR were associated with two-fold increased risks of ER−PR− BC in Hispanics, with stronger associations after adjustment for current BMI. Among NHWs, borderline trends were seen for WHtR (P trend =0.07) and WHR (P trend =0.09).
Joint associations of abdominal and overall obesity with breast cancer risk among Hispanics
Since the association with abdominal obesity among Hispanics did not differ significantly by ER/PR status, we examined the joint role of overall and abdominal obesity for all BCs combined ( Table 5 ). Among overweight Hispanics (BMI 25.0-29.9 kg/m 2 ), BC risk was significantly reduced among those with small waist (≤88 cm) or hip (≤106.3 cm) circumference or low WHR (≤0.85) or WHtR (≤0.56), but not among those with large waist or hip circumference or those with high WHR or WHtR. In contrast, among obese Hispanics (BMI ≥30 kg/m 2 ), risk reductions were of similar magnitude, regardless of abdominal obesity.
Genetic ancestry, body size and breast cancer risk among Hispanics
In the subset of premenopausal Hispanics with available DNA, there was some variation in body size associations by genetic ancestry (Table 6 ). For ER+PR+ BC, there was a pattern of inverse associations with current BMI (P trend =0.06 after adjustment for young-adult BMI) and weight gain (P trend =0.04) among Hispanics with lower (≤46%) IA ancestry only. Similarly, for ER−PR− BC, the inverse association with weight gain was seen in those with lower IA ancestry only. Young-adult BMI was inversely associated with ER+PR+ BC regardless of IA ancestry, and with ER−PR− BC among Hispanics with higher (>46%) IA ancestry only.
For the analyses of abdominal obesity by genetic ancestry, all BCs were combined ( Table  6 ). Associations of waist circumference (P trend =0.01) and WHtR (P trend =0.07) were somewhat stronger among Hispanics with higher (>46%) IA ancestry.
Discussion
This pooled case-control analysis of over 1,200 premenopausal Hispanic women is the largest study to date to evaluate associations between body size and BC risk in U.S. Hispanics. Regardless of tumor hormone receptor status, young-adult BMI was inversely associated with breast cancer risk, whereas height and waist and hip circumferences were associated with increased risk. Current BMI was associated with reduced risk of ER+PR+ BC, with the largest reductions in risk found in Hispanics who had an elevated BMI as young adults and currently were overweight or obese. Genetic ancestry of Hispanic women appeared to modify some of the body size associations. These findings provide evidence that overall and abdominal obesity play an important role in BC etiology among premenopausal Hispanic women, as has been reported for NHWs, and contribute to the sparse and inconsistent epidemiologic data on body size and premenopausal BC risk in Hispanics (6) (7) (8) (9) .
Adult obesity has been associated with reduced risk of premenopausal BC risk in metaanalyses of primarily NHW women (3, 19, 20) . Similarly in Hispanic women, we found an inverse association with current obesity that was independent of young-adult BMI and abdominal obesity, although the association was limited to ER+PR+ BC. Furthermore, the reductions in risk were highest for women with higher adiposity throughout adulthood, thus emphasizing the importance of considering young-adult BMI when examining associations with current BMI and weight gain, especially in populations, such as Hispanics, who have a higher prevalence of overweight and obesity, even at young ages (12) . In our pooled dataset, 36% of premenopausal Hispanic controls had a young-adult BMI in the highest quartile (>24.1 kg/m 2 ) compared to 15% among NHWs. In contrast, for ER−PR− BC, no significant inverse associations remained for current BMI after adjustment for young-adult BMI and abdominal obesity, suggesting that current obesity may be an important protective factor for hormone responsive tumors only. The lower BC risk among obese women has been attributed to more frequent anovulatory menstrual cycles and lower estrogen concentrations (21), although there is evidence that menstrual cycle characteristics, self-reported infertility, and polycystic ovary syndrome do not explain the inverse associations with obesity (22, 23), suggesting the importance of other mechanisms yet to be identified.
Consistent with studies in NHW women (24-27), we found strong inverse associations with young-adult BMI in Hispanic women, both for ER+PR+ and ER−PR− BC. We previously reported inverse associations with adolescent obesity in Hispanics (8, 10) and NHWs (8) , particularly in premenopausal women with lifelong obesity (10) . Inverse associations with childhood or adolescent obesity have also been reported for NHW women (22, 28-31). Although the underlying mechanisms remain unclear, these findings suggest that early-life adiposity exerts a long-lasting influence on premenopausal BC risk.
In Hispanics, waist and hip circumference and WHtR were strongly associated with increased risk of both ER+PR+ and ER−PR− BC. For ER+PR+ BC, however, associations emerged only after adjustment for current BMI, whereas for ER−PR− BC, adjustment for BMI strengthened the positive associations. Some studies in NHWs have also shown that adjustment for BMI strengthened the associations with waist (32, 33), hip (33), or WHR (32, 34). We found no association with WHR in Hispanics, but a strong association with WHtR, an abdominal obesity measure that has previously not been examined in Hispanic women. Positive associations with WHR have been reported for NHWs (35, 36), with associations limited to ER+PR+ (37) or ER−(38) disease in some studies. In contrast to Hispanics, we found no evidence of association with abdominal obesity in NHWs, in agreement with other studies (9, (39) (40) (41) (42) , but unlike a recent meta-analysis that reported a positive association with WHR in NHW women (3) . The reasons for the differences in abdominal obesity associations between Hispanics and NHWs in our pooled analysis are not obvious. Abdominal obesity may affect premenopausal BC risk through hormonal, metabolic and inflammatory mechanisms (2, 43) , and it has been suggested that abdominal adipose tissue may be metabolically more active than peripheral adipose tissue (44) .
The 4-CBCS, to our knowledge, is the only study that examined possible variations in body size associations among Hispanics by genetic ancestry (8) . Using a different set of AIMs in a population with a more limited range of genetic admixture than the SFBCS, associations with BMI and WHR did not differ by genetic ancestry. In contrast, we found that associations with adiposity measures were different for Hispanics, depending on the degree of genetic admixture: inverse associations of ER+PR+ BC with BMI and weight gain were limited to Hispanics with lower IA ancestry, whereas for abdominal obesity, associations with BC risk overall were limited to those with higher IA ancestry. These results highlight the importance of genetic factors and call for further evaluation.
Our analysis has several strengths, including the population-based design, the large sample size, measurements of body size, comprehensive assessment of other BC risk factors by inperson interview, and availability of information on tumor ER and PR status for most cases. The use of measured height for BMI calculation was particularly important, since in the SFBCS, 22% of Hispanics did not know their height. Although we measured weight at interview, we used self-reported weight during the reference year to calculate BMI because of concern about disease-and treatment-related weight gain or loss. In a sensitivity analysis limited to women with both measured and self-reported weight and height, we found similar associations with BMI based on self-reported or measured height and weight (data not shown). Furthermore, the correlation between self-reported and measured weight was high both in premenopausal cases (r=0.88) and controls (r=0.91). Some limitations also need to be considered. Participation rates differed between the two studies, but the results for Hispanic women were generally consistent across the two studies. Although the pooled analysis included a large sample of premenopausal Hispanic women and was hypothesis driven, the sample size was limited for certain subgroup analyses that considered multiple factors jointly and for analyses of ER−PR− disease. Furthermore, the investigation of modifying factors resulted in many comparisons, possibly leading to false-positive results. We relied on self-reported young-adult weight and the two studies assessed weight at different ages. Data harmonization to estimate average weight in a woman's twenties may not have been optimal and introduced non-differential misclassification, possibly causing the associations with weight gain to be attenuated. BMI, a widely used measure of body fat, does not distinguish between lean and fat mass (45) , or account for differences in body fat between individuals with the same BMI or across different racial/ethnic groups (46) (47) (48) . The analyses of abdominal obesity were based on measurements taken after diagnosis which may have introduced some misclassification. For example, within 12 months of treatment chemotherapy and endocrine therapy have been linked to increases in central fat, regardless of changes in body weight (49) . Finally, our analyses by genetic ancestry were limited by the range of admixture, as only U.S. Hispanics were included.
In conclusion, our findings highlight that body size throughout the premenopausal years has a major influence on BC risk and suggest that, in Hispanics, associations with overall and abdominal obesity are similar to those previously reported for NHW women, especially when considering tumor hormone receptor status. The association between abdominal obesity and ER−PR− BC is particularly important since few risk factors have been identified for this tumor subtype (50) (51) (52) , which is more common among Hispanics than NHWs (53) . Given that obesity and weight gain are associated with increased BC risk after menopause, when BC is diagnosed more frequently than at younger ages, avoiding weight gain and maintaining a healthy weight are important in both Hispanic and non-Hispanic populations, even at a young age, because of the long-term adverse effects of obesity on cancer and other chronic disease risk later in life. 1 Percentages may not add up to 100% due to rounding.
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